GGrantIndex
← Leaderboards

James Balow

National Institute Of Diabetes And Digestive And Kidney Diseases

$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

By mechanism

Top collaborators

No co-investigators on record.

Most similar at National Institute Of Diabetes And Digestive And Kidney Diseases

Same institution · by research overlap

Others in their field

Top investigators on “Monitor

Research focus

MonitorPharmacotherapyMembranous GlomerulonephritisKidneyRenal FunctionDoseReportingUnited States National Institutes Of HealthSafetyDiabetes MellitusBlood GlucoseBiopsyInsulinLeadLupusClinical ResearchInsulin ResistancePharmaceutical PreparationsImmunosuppressive AgentsNephrologyCyclosporineEffectivenessAdrenal Cortex HormonesBase

Grant awards (32)

Multidisciplinary Collaborative Clinical Research, Protocol Navigation, Monitoring Compliance, and Other Clinical Services in NIDDK Program Area Diseases$419,283
ZID · FY2021 · DK · contact PI
Multidisciplinary Collaborative Clinical Research, Protocol Navigation, Monitoring Compliance, and Other Clinical Services in NIDDK Program Area Diseases$569,202
ZID · FY2020 · DK · contact PI
Multidisciplinary Collaborative Clinical Research, Protocol Navigation, Monitoring Compliance, and Other Clinical Services in NIDDK Program Area Diseases$823,936
ZID · FY2019 · DK · contact PI
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases$914,364
ZID · FY2018 · DK · contact PI
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases$914,364
ZID · FY2017 · DK · contact PI
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases$569,792
ZID · FY2016 · DK · contact PI
Immunosuppressive drug therapy in lupus membranous nephropathy$306,811
ZIA · FY2016 · DK · contact PI
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases$577,591
ZID · FY2015 · DK · contact PI
Immunosuppressive drug therapy in lupus membranous nephropathy$311,011
ZIA · FY2015 · DK · contact PI
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases$671,045
ZID · FY2014 · DK · contact PI
Immunosuppressive drug therapy in lupus membranous nephropathy$206,475
ZIA · FY2014 · DK · contact PI
Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy$154,857
ZIA · FY2014 · DK · contact PI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases$767,049
ZID · FY2013 · DK · contact PI
Immunosuppressive drug therapy in lupus membranous nephropathy$236,015
ZIA · FY2013 · DK · contact PI
Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy$177,011
ZIA · FY2013 · DK · contact PI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases$864,620
ZID · FY2012 · DK · contact PI
Immunosuppressive drug therapy in lupus membranous nephropathy$266,037
ZIA · FY2012 · DK · contact PI
Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy$199,528
ZIA · FY2012 · DK · contact PI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases$1,216,570
ZID · FY2011 · DK · contact PI
Immunosuppressive drug therapy in lupus membranous nephropathy$374,329
ZIA · FY2011 · DK · contact PI
Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy$280,747
ZIA · FY2011 · DK · contact PI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases$1,437,333
ZID · FY2010 · DK · contact PI
Studies in Youths & Young Adults with Obesity & T2DM (07-DK-0115, 10-DK-0163)$727,715
ZIA · FY2010 · DK · contact PI
Immunosuppressive drug therapy in lupus membranous nephropathy$383,289
ZIA · FY2010 · DK · contact PI
03-DK-0245 (Effect of AC2993 (synthetic exendin-4) on pancreatic islet function)$207,918
ZIA · FY2010 · DK · contact PI
Secondary Prevention Trials For Recently Diagnosed Type 1 Diabetes Mellitus$103,959
ZIA · FY2010 · DK · contact PI
Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy$95,822
ZIA · FY2010 · DK · contact PI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases$1,506,257
ZID · FY2009 · DK · contact PI
Immunosuppressive drug therapy in lupus membranous nephropathy$430,359
ZIA · FY2009 · DK · contact PI
Sirolimus Therapy in Idiopathic and Lupus Membranous Nephropathy$107,590
ZIA · FY2009 · DK · contact PI
Beta-Cell Rest in Adolescents and Young Adults with Type 2 Diabetes (07-DK-0115)$107,590
ZIA · FY2009 · DK · contact PI
Beta-Cell Rest in Adolescents and Young Adults with Type 2 Diabetes (07-DK-0115)$445,197
Z01 · FY2008 · DK · contact PI